NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MygeA.01141.a: Putative 1-phosphofructokinase (MG_063)

Target Characteristics

from organism: Mycoplasma genitalium ATCC 33530 / G-37 / NCTC 10195
most recent status: target approved
center reference id: MygeA.01141.a
is community request: False
associated disease:
NIH risk group: unclassified
is select agent: False
NIH priority
pathogens category:
C

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Molecular models

Method Results
comparative modelling Robetta_10516

External Resources

Resource Reference ID
PATRIC ID: fig|243273.25.peg.64
UniProt: Q49396

Enzyme & Pathway Information

Pathway Pathway ID EC Number
fructose degradation PWY0-1314 2.7.1.56

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MQNITKESKI WIVNYACAID YYVDLNKQKN SVLIPGGKGI NVAIVMKSLG FDPTVITFLG QPTKNLFLEL VKPYDLNIVS FISETKTRIN LKLLKDEKTT EINDLSPLIT DANLTELLTF LKANVKNNDL VIINGRFKFE ALEKVLNLVF TLTENVVIDV DESKMLTLLN QSKPLVMKPN IDEFQTMINT FFHDQQSLIA AIKKFHYCKL LLLSDGDKGA YLFDQNKLLF VSSITPKQVV STTGAGDTLL AVFLANLILK VDLKTALIKA TNYASATISK LGVVDSKDKI SVITPKSYYL

NT Sequence
TTGCAAAACA TAACCAAAGA AAGCAAAATC TGAATAGTTA ATTACGCTTG CGCAATTGAT TATTATGTTG ATTTAAACAA GCAAAAAAAT AGTGTTTTAA TACCTGGTGG TAAGGGGATT AATGTTGCTA TTGTAATGAA ATCACTTGGT TTTGATCCAA CTGTCATTAC TTTTTTGGGA CAACCCACTA AAAACTTATT TTTAGAGTTG GTAAAACCTT ATGATCTAAA TATAGTTAGC TTCATTTCTG AAACTAAAAC AAGAATTAAC CTTAAGTTAT TAAAAGATGA AAAAACTACT GAAATTAATG ATTTAAGTCC TTTAATAACA GATGCTAATC TAACTGAATT GTTAACTTTT TTAAAAGCTA ATGTTAAGAA TAATGATTTG GTTATCATCA ACGGAAGATT TAAATTTGAA GCTTTAGAAA AAGTTCTAAA CTTGGTCTTT ACATTAACAG AAAATGTGGT TATAGATGTT GATGAAAGCA AAATGTTAAC GCTTTTAAAT CAGTCTAAAC CACTAGTTAT GAAACCTAAC ATTGATGAGT TTCAAACTAT GATTAATACT TTTTTTCACG ATCAACAAAG CTTAATAGCA GCAATTAAAA AATTTCATTA CTGTAAGCTC TTATTATTAT CTGATGGTGA CAAAGGAGCT TATCTTTTTG ATCAGAATAA GTTATTGTTT GTAAGTTCTA TCACTCCTAA ACAAGTAGTT AGCACCACAG GAGCAGGTGA TACTTTGTTG GCAGTTTTTT TAGCAAATTT GATTCTAAAG GTAGATTTAA AAACTGCTTT GATTAAAGCA ACTAACTATG CAAGTGCAAC AATTAGTAAG TTAGGTGTTG TTGATAGTAA AGACAAAATT AGTGTTATAA CCCCAAAAAG TTACTATTTA

© 2020 Seattle Children's Research Institute. All rights reserved.